Mumbai: Private equity and venture capital (PE/VC) investments in India’s healthcare sector surged 621 per cent year on year and 878 per cent quarter on quarter to $3.1 billion in Q3 2026, making it the second-largest sector by investment value, according to the latest EY-IVCA monthly PE/VC roundup.
The sector recorded 28 deals during the quarter, compared with 19 in Q2 2026. Monthly deal activity also picked up, with 11 deals in September, against eight in August and six in July.
The sector recorded 28 deals during the quarter, compared with 19 in Q2 2026. Monthly deal activity also picked up, with 11 deals in September, against eight in August and six in July.
PE/VC investments in healthcare stood at $1.1 billion in September, marking a 465 per cent increase year on year.
The quarter also saw KKR’s $1.4 billion acquisition of Medicover India, the largest PE/VC deal across sectors during the period.
In terms of PE/VC-backed IPO exits since 2021, healthcare ranked fifth by deal volume. However, it recorded the third-highest exit value in Q3 2026, at $1.4 billion.
